CardioGenics Holdings (CardioGenics Holdings) EV-to-EBITDA : 0.00 (As of Jun. 08, 2024)

CardioGenics Holdings EV-to-EBITDA Chart

CardioGenics Holdings Annual Data
	Trend	Jul06	Jul07	Jul08	Oct09	Oct10	Oct11	Oct12	Oct13	Oct14	Oct15
EV-to-EBITDA		Get a 7-Day Free Trial					-2.49	-6.72	-2.50	-4.80	-4.90

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
EV-to-EBITDA	Get a 7-Day Free Trial															-2.61	-1.67	-4.17	-4.90	-4.20

Competitive Comparison of CardioGenics Holdings's EV-to-EBITDA

For the Diagnostics & Research subindustry, CardioGenics Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's EV-to-EBITDA falls into.

CardioGenics Holdings EV-to-EBITDA Calculation

CardioGenics Holdings's EV-to-EBITDA for today is calculated as:

CardioGenics Holdings's current Enterprise Value is $0.00 Mil.
CardioGenics Holdings's EBITDA for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CardioGenics Holdings  (OTCPK:CGNH) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

CardioGenics Holdings's PE Ratio for today is calculated as:

CardioGenics Holdings's share price for today is $0.0001.
CardioGenics Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.011.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

CardioGenics Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description